SCHEMBL23704571

SCHEMBL23704571

CCCCCCN(CCCCCC)c1ccc2cc(C(=O)c3cc4ccc(N(CCCCCC)CCCCCC)cc4oc3=O)c(=O)oc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.61
▸ MEN1 O00255 3/20 0.60
▸ MAPT P10636 3/20 0.60
▸ KMT2A Q03164 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ SLC16A3 O15427 3/20 0.60
▸ ATM Q13315 2/20 0.60
▸ HPGD P15428 2/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ SLC16A1 P53985 2/20 0.60
▸ USP2 O75604 1/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ ALOX15 P16050 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ MAOA P21397 2/20 0.56
▸ CYP19A1 P11511 1/20 0.50
▸ GBA1 P04062 1/20 0.48
▸ NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2028054 0.95 MAOB (0.63) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL10618151 0.90 MAOB (0.66) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL12039998 0.90 MAOB (0.57) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL13432107 0.89 MAOB (0.66) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL15129059 0.86 SLC16A3 (0.77) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL51872 0.84 MEN1 (0.82) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL13328547 0.83 MAOB (0.62) MAOBMEN1MAPTKMT2AALDH1A1
Acetone SCHEMBL15015702 0.82 MEN1 (0.82) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL12039997 0.82 MAOB (0.53) MAOBMEN1MAPTKMT2AALDH1A1
SCHEMBL15138691 0.81 SLC16A3 (0.81) MAOBMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583948-B2 Photohardenable compositions, methods, and a stabilizer QUADRATIC 3D, INC. (US) 2026-03-24 — — US disclosed
US-20240018277-A1 PHOTOHARDENABLE COMPOSITIONS, METHODS, AND A STABILIZER QUADRATIC 3D, INC. 2024-01-18 — — US disclosed
WO-2022212557-A1 PHOTOHARDENABLE COMPOSITIONS, METHODS, AND A STABILIZER QUADRATIC 3D, INC. (US) 2022-10-06 — — WO disclosed
WO-2021154897-A1 PHOTOHARDENABLE COMPOSITIONS INCLUDING AN UPCONVERTING COMPONENT AND METHODS QUADRATIC 3D, INC. (US) 2021-08-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583948-B2 Photohardenable compositions, methods, and a stabilizer NOX4, LCP1, TERB1 MAOB 3961/4885MEN1 4262/4885MAPT 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback